medicago

EUIPO EUIPO 2018 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark medicago was filed as Figurative mark on 08/02/2018 at the European Union Intellectual Property Office.
It was registered as a trademark on 10/17/2019. The current status of the mark is "Trademark registered".

Logodesign (Wiener Klassifikation)

#Letters presenting a special form of writing #Blue

Trademark Details Last update: February 9, 2024

Trademark form Figurative mark
File reference 017938300
Application date August 2, 2018
Publication date September 10, 2018
Entry date October 17, 2019
Expiration date August 2, 2028

Trademark owner

4100-1155, boulevard René-Lévesque Ouest
H3B 3V2 Montréal (Québec)
CA

Trademark representatives

9 avenue Percier 75008 Paris FR

Objection / Complaint

12/10/2018: Art. 8(4) Likelihood of confusion
Applicant
Medigoo Oy

goods and services

5 Pharmaceutical and medicinal preparations and substances namely human vaccines, therapeutic proteins and antibodies
35 Operation of a company specializing in the development, manufacture and sale of pharmaceuticals, pharmaceuticals ingredients, vaccines, therapeutic proteins and antibodies
40 Manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies for others
42 Research and development in the field of vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; medical and scientific research regarding clinical trial studies on new vaccine candidates

Trademark history

Date Document number Area Entry
January 9, 2024 Transfer / Change of address, Published

ID: 11017938300